(Q33731687)

29 July 2017

title

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease (English)

1 reference

29 July 2017

0 references

1 reference

C W Christine

1

1 reference

29 July 2017

P A Starr

2

1 reference

29 July 2017

P S Larson

3

1 reference

29 July 2017

J L Eberling

4

1 reference

29 July 2017

W J Jagust

5

1 reference

29 July 2017

R A Hawkins

6

1 reference

29 July 2017

H F VanBrocklin

7

1 reference

29 July 2017

J F Wright

8

1 reference

29 July 2017

K S Bankiewicz

9

1 reference

29 July 2017

M J Aminoff

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

14 October 2009

1 reference

29 July 2017

1 reference

29 July 2017

volume

73

1 reference

29 July 2017

issue

20

1 reference

29 July 2017

page(s)

1662-1669

1 reference

Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Adeno-associated virus vectors can be efficiently produced without helper virus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Development and validation of a geriatric depression screening scale: a preliminary report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

A randomized trial of deep-brain stimulation for Parkinson's disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839805

Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19828868

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19828868

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19828868

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E3181C29356

1 reference

29 July 2017

1 reference

29 July 2017

1 reference